Preoperative prognostic nutritional index predicts short- and long-term outcomes after liver resection in patients with hepatocellular carcinoma.
hepatocellular carcinoma
prognostic nutritional index
surgical outcomes
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
16
05
2020
accepted:
14
10
2020
entrez:
8
2
2021
pubmed:
9
2
2021
medline:
9
2
2021
Statut:
ppublish
Résumé
The prognostic nutritional index (PNI) is one of the immune parameters calculated on the basis of the serum albumin and the total lymphocyte count. The aim of the present study was to investigate the prognostic significance of the PNI for short- and long-term outcomes after liver resection for patients with hepatocellular carcinoma (HCC). Data from 162 surgically treated patients with HCC (without any previous treatment) were retrospectively analyzed. The cutoff value of preoperative PNI was 45.0, which was calculated by a receiver operating characteristic curve for predicting the recurrence of HCC after liver resection. Patients were divided into low (n=86) and high (n=76) PNI groups. In short-term outcomes, patients in the low PNI group were more likely to experience postoperative complications compared with those in the high PNI group. The 5-year disease-free survival (DFS) rate in the low PNI group was significantly lower compared with that in the high PNI group (20.5% vs. 48.7%). In the multivariate analysis, a low PNI was an independent prognostic factor for DFS (HR, 1.65; 95% CI, 1.00-2.71). In conclusion, the preoperative PNI may be a prognostic factor for evaluating short- and long-term outcomes after liver resection in patients with HCC.
Identifiants
pubmed: 33552271
doi: 10.3892/ol.2020.12414
pii: OL-0-0-12414
pmc: PMC7798109
doi:
Types de publication
Journal Article
Langues
eng
Pagination
153Informations de copyright
Copyright © 2021, Spandidos Publications.
Références
Transplantation. 2013 Dec 15;96(11):1008-12
pubmed: 24113512
HPB (Oxford). 2018 Oct;20(10):888-895
pubmed: 29853431
PLoS One. 2017 Mar 29;12(3):e0174769
pubmed: 28355305
Oncotarget. 2016 Dec 6;7(49):81611-81620
pubmed: 27835570
Oncotarget. 2016 Sep 6;7(36):58543-58552
pubmed: 27344182
Ann Surg Oncol. 2015 Dec;22(13):4138-48
pubmed: 25801356
Am J Surg. 1980 Jan;139(1):160-7
pubmed: 7350839
HPB (Oxford). 2017 May;19(5):458-464
pubmed: 28190710
Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1001-5
pubmed: 6438478
Br J Surg. 2013 Oct;100(11):1523-30
pubmed: 24037576
Oncol Res Treat. 2016;39(11):712-719
pubmed: 27855385
J Hepatobiliary Pancreat Sci. 2020 Jul;27(7):388-395
pubmed: 32162483
HPB (Oxford). 2017 Aug;19(8):695-705
pubmed: 28479010
Ann Surg. 2020 Apr;271(4):693-700
pubmed: 30308614
Ann Surg Oncol. 2021 Jan;28(1):439-446
pubmed: 32562115
Ann Surg. 2020 Aug;272(2):342-351
pubmed: 32675548
Oncol Rep. 2008 Sep;20(3):651-6
pubmed: 18695919
Am J Surg. 2016 Jul;212(1):122-7
pubmed: 26421412
World J Surg Oncol. 2016 Nov 3;14(1):279
pubmed: 27809860
N Engl J Med. 2019 Apr 11;380(15):1450-1462
pubmed: 30970190
Mol Clin Oncol. 2016 Nov;5(5):567-574
pubmed: 27900086
Gynecol Oncol. 2012 Oct;127(1):107-13
pubmed: 22710071
Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9
pubmed: 16327492
Ann Surg. 2015 Jun;261(6):1173-83
pubmed: 24950264
Pathol Int. 2015 Dec;65(12):644-51
pubmed: 26530981
Ann Surg. 2017 Jun;265(6):1201-1208
pubmed: 27355265
J Surg Res. 2014 Dec;192(2):402-8
pubmed: 24998425
J Gastroenterol Hepatol. 2008 Dec;23(12):1869-73
pubmed: 18717761
Surg Today. 2012 Jan;42(1):1-7
pubmed: 22116397
J Surg Oncol. 2008 Dec 1;98(7):540-4
pubmed: 18937231
Ann Thorac Surg. 2017 Jul;104(1):296-302
pubmed: 28433217
Breast. 2020 Apr;50:141-148
pubmed: 31607527